Severe sepsis due to severe falciparum malaria and leptospirosis co-infection treated with activated protein C

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Srinivas, Rajagopala ^a   Agarwal, Ritesh ^a   Gupta, Dheeraj ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ARTESUNATE; CEFTRIAXONE; DOXYCYCLINE; PROTEIN C;

ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ADULT; ARTICLE; CASE REPORT; CONJUNCTIVAL HEMORRHAGE; DROWSINESS; FEVER; HEMODIALYSIS; HEMOLYSIS; HEPATITIS; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; JAUNDICE; LABORATORY TEST; LEPTOSPIROSIS; MALARIA FALCIPARUM; MALE; PERONEUS NERVE PARALYSIS; SENSORY DYSFUNCTION; SEPSIS; SEROLOGY; THROMBOSIS PREVENTION; ANIMAL; BLOOD; ISOLATION AND PURIFICATION; LEPTOSPIRA; MICROBIOLOGY; PARASITOLOGY; PLASMODIUM FALCIPARUM;

ADULT; ANIMALS; HUMANS; LEPTOSPIRA; LEPTOSPIROSIS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PROTEIN C; SEPSIS;

EID: 34247489678     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-42     Document Type: Article

References (21)

1. Severe falciparum malaria. PF Beales DA Warrell, Trans R Soc Trop Med Hyg 2000 94 suppl 1 1 90
2. Co-infection of malaria and leptospirosis. C Wongsrichanalai CK Murray M Gray RS Miller P MCDaniel WJ Liao AL Pickard AJ Magill, Am J Trop Med Hyg 2003 68 583 585 12812350
3. Susceptibility of leptospira serovars to anti-malarial agents. CK Murray MW Ellis DR Hospenthal, Am J Trop Med Hyg 2004 71 685 686 15569805
4. Efficacy and safety of recombinant human recombinant protein C for severe sepsis. The recombinant human recombinant protein C worldwide evaluation in severe sepsis(PROWESS) study group. G Bernard JL Vincent PF Laterre SP LaRosa JF Dhainaut AL Rodriguez JS Steingrub GE Garber, N Engl J Med 2001 344 699 708 10.1056/NEJM200103083441001 11236773
5. Activated protein C in sepsis: down but not out, yet. R Agarwal A Nath, Crit Care 2006 10 416 16887006 10.1186/cc4988
6. Drotrecogin alfa (activated) in severe falciparum malaria. BJL Kendrick AG Gray A Pickworth MPR Watters, Anaesthesia 2006 61 899 902 10.1111/j.1365-2044.2006.04752.x 16922759
7. Drotrecogin alfa in tropical infections and refractory multi-organ failure. F Kapadia C Shirwadkar, Intensive Care Med 2006 32 1281 1282 10.1007/s00134-006-0230-6 16741686
8. Malaria. BM Greenwood K Bojang CJM Whitty GAT Targett, Lancet 2005 365 1487 1498 10.1016/S0140-6736(05)66420-3 15850634
9. Investigation of an outbreak of scrub typhus in the Himalayan region of India. A Sharma S Mahajan ML Gupta A Kanga V Sharma, Jpn J Infect Dis 2005 58 208 210 16116251
10. Evaluation of the ill returned traveller. N Bacaner ME Wilson, Clinics in Family Practice 2005 7 805 834
11. South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. NJ White, Lancet 2005 366 717 725 10.1016/S0140-6736(05)67761- 6 16125588
12. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria. S Hoontrakoon Y Suputtamongkol, Trop Med Int Health 1998 3 156 161 10.1111/j.1365-3156.1998.00198.x 9537279
13. Emerging leptospirosis, North India. R Chaudhry MM Premlatha S Mohanty B Dhawan KK Singh AB Dey, Emerg Infect Dis 2002 8 1527
14. Serodiagnosis of leptospirosis in Delhi using IgM enzyme linked immunosorbent assay. N Gupta RR Sambasiva P Bhalla SK Agarwal, Indian J Med Res 2004 120 557 558 15654143
15. Diagnosis of leptospirosis utilizing modified Faine's criteria. SS Kumar PS Shareek, J Assoc Physic India 2004 52 678 679
16. Malaria and the lung. WR Taylor NJ White, Clin Chest Med 2002 23 457 468 10.1016/S0272-5231(02)00004-7 12092039
17. Pulmonary manifestations in malaria. R Rajput H Singh S Singh Meena UC Tiwari, J Indian Med Assoc 2000 98 612 614 11258488
18. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. MS Riddle J LJackson JW Sanders, Clin Infect Dis 2002 34 1192 1198 10.1086/339810 11941545
19. Management of severe malaria:Interventions and controversies. G Pasvol, Infect Dis Clin N Am 2005 19 211 240 10.1016/j.idc.2004.10.007
20. New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). WL Macias SB Yan MD Williams SL Um GE Sandusky DW Ballard JS Planquois, Critical Care 2005 9 suppl 4 S38 S45 10.1186/cc3747 16168074
21. Source control in the management of severe sepsis and septic shock: an evidence based review. JC Marshall RV Maier M Jimenez P Dellinger, Crit Care Med 2004 32 suppl S513 523 10.1097/01.CCM.0000143119.41916.5D